drugset / Trial / NCT00868231
Efficacy of Aclidinium Bromide Administered in Chronic Obstructive Pulmonary Disease (COPD) Patients
RandomizedCrossoverDouble-blindTreatment
Summary
The main purpose of this study is to evaluate the efficacy, safety and tolerability of multiple doses of inhaled aclidinium bromide in moderate to severe COPD patients.
Timeline
- Start
- 2009-03
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aclidinium | Small molecule | 400 ug | Inhaled |
| Comparator | Tiotropium | Other / unclassified | 18 ug | Inhaled |